Skip to main content
      RT @ejdein1: Sustained remission is rare, should we settle for sustained low disease activity? Abst#0480 ESPOIR Cohort s

      Eric Dein ejdein1

      4 years 5 months ago
      Sustained remission is rare, should we settle for sustained low disease activity? Abst#0480 ESPOIR Cohort says no, get remission if possible for better radiographic (Sharp) and fxnal (HAQ) scores. Maybe perfect isn't enemy of good? @RheumNow. #ACR20 https://t.co/QNQn9n27rm
      RT @RichardPAConway: Dr Alba reports that in GCA angiotensin II system appears to be activated. Losartan reversed change

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Alba reports that in GCA angiotensin II system appears to be activated. Losartan reversed changes and reduced inflammatory markers. Possible role in GCA treatment? @rheumnow #ACR20 Abstr#510 https://t.co/IPp3lD1BUH
      RT @Janetbirdope: Early RA pts may develop chronic widespread pain. Not all have fibromyalgia. Multiple areas of pain &a

      Janet Pope Janetbirdope

      4 years 5 months ago
      Early RA pts may develop chronic widespread pain. Not all have fibromyalgia. Multiple areas of pain & inflammation ^ chronic pain & other factors ie women high initial pain longer symptoms @CRASCRRheum @RheumNow #ACR20 abstr#187 1/3 at onset have regional pain 1/4 at 1yr https://t.co/7qOxH4h7Dd https://t.co/IFO1uwyR0o
      RT @RichardPAConway: Dr Ferrada and colleagues assess relapsing polychondritis cohort for VEXAS. Prevalence of 8%. Male

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Ferrada and colleagues assess relapsing polychondritis cohort for VEXAS. Prevalence of 8%. Male sex or age at onset >50 + MCV >100 + platelet count< 200 classified between VEXAS and RP with 100% sens and 96% spec @rheumnow @petercgrayson #ACR20 Abstr#509 #ACRbest https://t.co/5QMu4Y6xSH
      RT @bella_mehta: #ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity

      Bella Mehta bella_mehta

      4 years 5 months ago
      #ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow
      RT @bella_mehta: #ACR20 Basic Science Year-in-review Really important work by @danaorange showing PRIME cells can predic

      Bella Mehta bella_mehta

      4 years 5 months ago
      #ACR20 Basic Science Year-in-review Really important work by @danaorange showing PRIME cells can predict flares in #RheumatoidArthritis patients #HSSrheum @RheumNow https://t.co/XTqqinAN2a https://t.co/24HkqgHS0H
      RT @HSS_PIC: Proud of #HSSRheum! Check out the full list of our 76 Abstracts and 27 moderator and speaker sessions at #A

      HSS Physician-in-Chief HSS_PIC

      4 years 5 months ago
      Proud of #HSSRheum! Check out the full list of our 76 Abstracts and 27 moderator and speaker sessions at #ACR20 Convergence here: https://t.co/OoQSzoRxGq. Special congratulations to our two awardees - Roberta Horton and Dr. Jane Salmon! https://t.co/cDkzgFtEH3
      RT @bella_mehta: Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Dev

      Bella Mehta bella_mehta

      4 years 5 months ago
      Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Development and Validation of an #artificial_intelligence Approach for the Detection of Radiographic Sacroiliitis using MRI @RheumNow
      RT @bella_mehta: #ACR20 year in review by @JYazdanyMD latest data PEXIVAS and SEMIRA trials on corticosteroids - would y

      Bella Mehta bella_mehta

      4 years 5 months ago
      #ACR20 year in review by @JYazdanyMD latest data PEXIVAS and SEMIRA trials on corticosteroids - would you change your clinical practice to minimize even low dose Corticosteroids in RA and Vasculitis? @RheumNow https://t.co/l7PTyANpjq https://t.co/MRGbsjaGae
      RT @ejdein1: Ready for #ACR20 with an obstructed view. @RheumNow https://t.co/oFVc90DpEM

      Eric Dein ejdein1

      4 years 5 months ago
      Ready for #ACR20 with an obstructed view. @RheumNow https://t.co/oFVc90DpEM
      RT @ejdein1: ACR president Dr. Ellen Gravallese: "We should be in the room where it happens" because "our knowledge and

      Eric Dein ejdein1

      4 years 5 months ago
      ACR president Dr. Ellen Gravallese: "We should be in the room where it happens" because "our knowledge and insights are highly relevant" #ACR20 @RheumNow #Hamilton
      RT @ejdein1: "Educational conferences will never be the same" Ellen Gravallese, MD. Already in action at #ACR20 @RheumNo

      Eric Dein ejdein1

      4 years 5 months ago
      "Educational conferences will never be the same" Ellen Gravallese, MD. Already in action at #ACR20 @RheumNow
      RT @ejdein1: Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by inte

      Eric Dein ejdein1

      4 years 5 months ago
      Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by intervening before infection occurs. #LTF, @RheumNow.
      RT @ejdein1: Eric Rubin, MD, editor-in-chief @NEJM: "All of the vaccines are based on the same hypothesis". Scary though

      Eric Dein ejdein1

      4 years 5 months ago
      Eric Rubin, MD, editor-in-chief @NEJM: "All of the vaccines are based on the same hypothesis". Scary thought in relying in one solution #ACR20. @RheumNow
      ×